Literature DB >> 21847633

Lentivirus-mediated overexpression of microRNA-199a inhibits cell proliferation of human hepatocellular carcinoma.

Xiao Qin Jia1, Hai Qing Cheng, Xu Qian, Chuan Xiu Bian, Zhu Mei Shi, Jian Ping Zhang, Bing Hua Jiang, Zhen Qing Feng.   

Abstract

microRNA-199a (miR-199a) is a highly conserved miRNA, always deregulated in numerous human tumors. The results of microarray analysis indicated that miR-199a was frequently downregulated in hepatocellular carcinoma (HCC). The expression levels of miR-199a in 11 pairs of matched HCC neoplastic and adjacent non-neoplastic tissues, 5 HCC cell lines and liver cell line L02 were examined by quantitative real-time PCR analysis. We found miR-199a was significantly down-regulated in HCC tissues when compared with pair-matched adjacent non-tumor tissues. We also found the expression level of miR-199a was also substantially decreased in several human HCC cell lines including SMMC-7721, BEL-7402, BEL-7701, MHCC97H, and HepG2. To investigate the role of miR-199a in tumorigenesis, we developed a lentiviral vector for the expression of pre-miR-199a (Lenti-miR-199a). Lenti-miR-199a inhibited HCC cell proliferation in vitro and in vivo. Compared to parental cells or cells transfected with a control vector, the overexpression of microRNA-199a in the HCC cell lines HepG2 stably was showed to reduce cell proliferation in vitro and in vivo. Luciferase reporter assay revealed the regulation of miR-199a on 3'-UTR of HIF-1α. Further investigation confirmed that miR-199a significantly reduced the endogenous protein level of HIF-1α in hypoxia. MiR-199a inhibits cell proliferation in vitro and in vivo partly through down-regulation of HIF-1α in human HCC. Thus, these studies provide an important new insight into the pathogenesis of human HCC and it may open a new perspective for the development of effective gene therapy for human HCC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21847633     DOI: 10.1007/s12013-011-9263-8

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  32 in total

Review 1.  Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury.

Authors:  Tae Jin Lee; Xiaoyi Yuan; Keith Kerr; Ji Young Yoo; Dong H Kim; Balveen Kaur; Holger K Eltzschig
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

2.  Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.

Authors:  Abdel-Rahman Nabawy Zekri; Amira Salah El-Din Youssef; Eman Desouky El-Desouky; Ola Sayed Ahmed; Mai M Lotfy; Auhood Abdel-Monem Nassar; Abeer A Bahnassey
Journal:  Tumour Biol       Date:  2016-06-06

3.  Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model.

Authors:  L D'Abundo; E Callegari; A Bresin; A Chillemi; B K Elamin; P Guerriero; X Huang; E Saccenti; E M A A Hussein; F Casciano; P Secchiero; G Zauli; G A Calin; G Russo; L J Lee; C M Croce; G Marcucci; S Sabbioni; F Malavasi; M Negrini
Journal:  Oncogene       Date:  2017-08-07       Impact factor: 9.867

Review 4.  OxymiRs in cutaneous development, wound repair and regeneration.

Authors:  Chandan K Sen; Sashwati Roy
Journal:  Semin Cell Dev Biol       Date:  2012-10-10       Impact factor: 7.727

5.  The microRNA miR-199a-5p down-regulation switches on wound angiogenesis by derepressing the v-ets erythroblastosis virus E26 oncogene homolog 1-matrix metalloproteinase-1 pathway.

Authors:  Yuk Cheung Chan; Sashwati Roy; Yue Huang; Savita Khanna; Chandan K Sen
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

Review 6.  MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches.

Authors:  E Callegari; L Gramantieri; M Domenicali; L D'Abundo; S Sabbioni; M Negrini
Journal:  Cell Death Differ       Date:  2014-09-05       Impact factor: 15.828

Review 7.  MicroRNAs and hepatitis C virus: toward the end of miR-122 supremacy.

Authors:  Thomas Walter Hoffmann; Gilles Duverlie; Duverlie Gilles; Abderrahmane Bengrine; Bengrine Abderrahmane
Journal:  Virol J       Date:  2012-06-12       Impact factor: 4.099

8.  Anti-tumor activity of a miR-199-dependent oncolytic adenovirus.

Authors:  Elisa Callegari; Bahaeldin K Elamin; Lucilla D'Abundo; Simonetta Falzoni; Giovanna Donvito; Farzaneh Moshiri; Maddalena Milazzo; Giuseppe Altavilla; Luciano Giacomelli; Francesca Fornari; Akseli Hemminki; Francesco Di Virgilio; Laura Gramantieri; Massimo Negrini; Silvia Sabbioni
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

Review 9.  Flexible and versatile as a chameleon-sophisticated functions of microRNA-199a.

Authors:  Shen Gu; Wai-Yee Chan
Journal:  Int J Mol Sci       Date:  2012-07-09       Impact factor: 6.208

10.  MicroRNAs Involved in Anti-Tumour Immunity.

Authors:  Hong W H Yu; Daniel M Y Sze; William C S Cho
Journal:  Int J Mol Sci       Date:  2013-03-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.